Palonosetron HCL Is a Preferred Treatment for Moderately Emetogenic Chemotherapies

Chemotherapy-induced nausea and vomiting (CINV) is an adverse event (AE) associated with cancer therapies that healthcare providers often underestimate. CINV can interfere with treatment compliance and adherence, and patients who experienced CINV in the first cycle of chemotherapy are almost four times more likely to experience it during subsequent treatment cycles.

How Can Oncology and ICU Nurses Work Together to Treat Critically Ill Patients With Cancer?

Oncology and ICU Nurses Working Together

Nurses in the intensive care unit (ICU) generally see patients with cancer only when they are extremely sick—not throughout the extensive cancer journey they go through before they get to the ICU. Educating and familiarizing ourselves, as ICU nurses, with a patient’s oncology plan, goals, and history can improve overall care. Learning at which points in the process of cancer treatment certain issues are more likely to arise, such as tumor lysis syndrome during high-dose induction, when a patient is most likely to be neutropenic during a stem cell transplant, and other general facts about oncology, can help improve the care we give. It helps us understand our patients as a whole. The oncology population is a huge part of medical intensive care, and encouraging critical care nurses and oncology nurses to collaborate can help improve the continuity of care and eliminate errors in the ICU.

Critical Care for Patients With Cancer

Critical Care for Patients With Cancer

Five to Ten Percent of patients with cancer will need to visit the intensive care unit (ICU) for a life-threatening condition. In fact, estimates suggest that nearly 30% of patients with esophageal cancer or acute leukemia and those undergoing allogenic stem cell transplantation will need ICU care.

An Oncology Nurse Discussed What It’s Also Like to Be a Patient

When an oncology nurse becomes a patient with cancer, the experience can shed light on the cancer journey and help other nurses comprehend what their patients go through. During a session at the 42nd Annual Congress in Denver, CO, as part of the annual Mara Mogensen Flaherty Memorial Lectureship, Patricia Jakel, RN, MN, AOCN®, an advanced practice nurse at UCLA Santa Monica Medical Center and an associate professor in the UCLA School of Nursing, shared her journey, describing the terror that comes with diagnosis, the frequent unsupportive social interactions, and the symptom burden.

Combination Drug Offers New Treatment Option for Relapsed Metastatic Colorectal Cancer

More than 130,000 new cases of colorectal cancers (CRCs) are diagnosed in the United States each year, representing 8% of all new annual cancer cases. The rate of patients with CRC surviving more than five years is 65.1%; however, patients with metastatic disease (mCRC) have a poorer prognosis, with only 13.5% surviving more than years. As many as 40% of patients with mCRC remain candidates for third-line therapy, with some patients requiring up to five lines of therapy because of drug resistance.

Drug Extends Overall Survival for Breast Cancer and Liposarcoma

Organizations Define Care Coordination and Transition Management Nursing Roles

Each year, the ONS Board of Directors sponsors a session at the ONS Annual Congress on a particularly important, high-impact topic. During a session at the 42nd Annual Congress in Denver, CO, the leadership chose the up-and-coming nursing role of care coordination and transition management.

Local Organizations Can Make a Big Difference in Cancer Care

supportive oncology services

I have the privilege of managing and being the sole provider in a unique program. I work in the Hereditary Cancer Program at Saint Louis University Cancer Center, where I provide risk assessment services and education about genetic testing to individuals and families in the region. It’s an amazing nursing role, and I can truly help people prevent cancer and manage their risk.

Less Sleep May Increase Risk of Death From Prostate Cancer

Prostate Cancer Risk

Men younger than 65 years who sleep less than six hours per night have an increased risk of death from prostate cancer, according to the results of a study presented at the American Association for Cancer Research 2017 annual meeting.

What Safe Handling and Administration Requirements Apply to Immunotherapy?

Safe handling immunotherapy

In a supplement to the April 2017 issue of the Clinical Journal of Oncology Nursing, ONS released its first set of recommendations for nurse education and safe handling principles regarding immunotherapy administration. ONS recommendations are based on best-available evidence and the anecdotal experiences of professionals at cancer centers with varied experiences in immunotherapy administration.